Allergy, Immunology, and Rheumatology: Highlighted e-Posters

Moderator(s)

• 

  Megan Cooper, MD, PhD

  Associate Professor
  Pediatrics
  Washington University
  Washington University in St. Louis
  St. Louis, Missouri, United States
• 

  Hilary Haftel, MD MHPE FAAP

  Senior Vice President, Education
  American Academy of Pediatrics
  University of Michigan
  Itasca, Illinois, United States

Presentations:

• 6:15 PM - 7:15 PM US CT

  Bifidobacteria-mediated immune system imprinting early in life
  

  Presenter: Bethany Henrick, PhD – Evolve Biosystems
• 6:15 PM - 7:15 PM US CT

  Maternal lipids regulate neonatal dendritic cells during development of allergic disease
  

  Presenter: Jacquelyn Lajiness, MD, PhD – Indiana University School of Medicine
• 6:15 PM - 7:15 PM US CT

  Presence of Disease-Associated Polymorphisms in Regions of Open Chromatin in Treatment-Naïve Pediatric Lupus
  

  Presenter: Joyce Hui-Yuen, MD, MS – Cohen Children's Medical Center
• 6:15 PM - 7:15 PM US CT

  Salivary MiRNA Profiles in Pediatric Eosinophilic Esophagitis
  

  Presenter: Kristin Lambert, PhD – Penn State College of Medicine
• 6:15 PM - 7:15 PM US CT

  Dupilumab in Children Aged ≥6–<12 Years Significantly Improves Signs and Symptoms of Atopic Dermatitis Assessed by SCORAD
  

  Presenter: Ana Rossi, MD – Sanofi Genzyme
• 6:15 PM - 7:15 PM US CT

  Dupilumab Improves EASI Regional Scores Across All Anatomical Regions in Children Aged ≥6–<12 Years With Severe Atopic Dermatitis
  

  Presenter: Brad Shumel, MD – Regeneron Pharmaceuticals, Inc.
• 6:15 PM - 7:15 PM US CT

  Long-Term Efficacy and Safety Data for Dupilumab in a Phase 3, Open-Label Extension Trial (LIBERTY AD PED-OLE) in Patients Aged ≥6 to <12 Years With Uncontrolled, Moderate-to-Severe Atopic Dermatitis (AD)
  

  Presenter: Dimittri Delevry, PharmD – Regeneron Pharmaceuticals, Inc.